PBX1 and central nervous system cancer: Analysis of both our glioma patient cohort and the database33 confirmed the low level of PBX1 exon 7 usage in GBM patients (Fig. 2g), indicating PTBP1-mediated exon skipping is a predominant event in malignant glioma.